Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of VONOZAN versus VOCINTI in healthy Thai volunteers under fasting conditions
TCTR20260806008Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of vonoprazan, sponsored by International Bio Service. Primary endpoints: Maximum plasma concentration (Cmax), AUC0-tlast and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
vonoprazan
Beyond the preview
Go deeper on TCTR20260806008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260806008.